Peripheral Blood Stem Cell TransplantationMultiple MyelomaTransplantation, AutologousHematopoietic Stem Cell TransplantationHematopoietic Stem Cell MobilizationMelphalanTransplantation ConditioningTransplantation, HomologousCombined Modality TherapyGranulocyte Colony-Stimulating FactorLeukapheresisAntigens, CD34Hematologic NeoplasmsStem Cell TransplantationBlood Component RemovalAntineoplastic Combined Chemotherapy ProtocolsCyclophosphamideTreatment OutcomeMyeloablative AgonistsBusulfanGraft vs Host DiseaseRemission InductionLymphoma, Non-HodgkinBone Marrow TransplantationGraft SurvivalAntineoplastic Agents, AlkylatingHematopoietic Stem CellsRecurrenceEtoposideThiotepaBoronic AcidsPyrazinesVincristineSalvage TherapyThalidomideCarmustineCytophagocytosisDisease-Free SurvivalAmyloidosisIfosfamideDexamethasoneSurvival RateRetrospective StudiesStem CellsCytarabineHematopoiesisHodgkin DiseasePrednisoneSurvival AnalysisCord Blood Stem Cell TransplantationDoxorubicinTransplantation ChimeraNeoplasmsTissue DonorsTime FactorsAntineoplastic AgentsPlasma CellsWhole-Body IrradiationMyeloma ProteinsBone MarrowInfectionLymphoma, T-CellPOEMS SyndromePlatelet CountHistocompatibilityFollow-Up StudiesImmunosuppressive AgentsHistocompatibility TestingCarboplatinBone Marrow PurgingLeukemia, Myeloid, AcuteTransplantation, IsogeneicParaproteinemiasLeukemiaVidarabineBlood Cell CountRecombinant ProteinsPrognosisLymphomaImmunophenotypingFatal OutcomeProspective StudiesBlood CellsCytomegalovirus InfectionsGraft vs Leukemia EffectFeasibility StudiesFlow CytometryBone Marrow CellsMyelodysplastic SyndromesAnemia, AplasticBlood Transfusion, AutologousLeukemia, Myelogenous, Chronic, BCR-ABL PositiveLymphocyte DepletionMaintenance ChemotherapyLiver TransplantationHematologic DiseasesT-LymphocytesLeukocytes, MononuclearOpportunistic InfectionsHistiocytosis, Non-Langerhans-Cell